class name | count |
---|---|
asterids | 50 |
rosids | 19 |
eudicotyledons | 7 |
Liliopsida | 5 |
class name | count |
---|---|
Apocynaceae | 46 |
Moraceae | 14 |
Ranunculaceae | 7 |
Asparagaceae | 4 |
Asteraceae | 4 |
Brassicaceae | 3 |
Fabaceae | 2 |
Hyacinthaceae | 1 |
br08003 Category | # of metabolite |
---|---|
Cardanolide | 20 |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q16637 | Survival motor neuron protein | Unclassified protein | C00003612 C00003613 C00003625 C00003632 C00003633 C00030102 C00032211 C00035466 | 4 / 1 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00003612 C00003613 C00003632 C00003633 C00030102 C00032211 C00035466 | 7 / 37 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00003612 C00003613 C00003632 C00003633 C00030102 C00032211 C00035466 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00003625 C00003632 C00003633 C00035466 | 11 / 10 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003625 C00003633 | 1 / 1 |
Q99700 | Ataxin-2 | Unclassified protein | C00003625 C00003633 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00003625 C00003633 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00003625 C00003633 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00003625 C00003633 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00003625 C00003633 | 0 / 0 |
P68871 | Hemoglobin subunit beta | Secreted protein | C00003632 C00035466 | 4 / 4 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003625 C00003633 | 0 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00003625 C00003633 | 1 / 0 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00003633 | 5 / 2 |
P17252 | Protein kinase C alpha type | Alpha | C00003633 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00003633 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00003633 | 2 / 2 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00003633 | 0 / 0 |
A2TJX0 | Krueppel-like factor 5 | Unclassified protein | C00003633 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00003633 | 3 / 2 |
P00918 | Carbonic anhydrase 2 | Lyase | C00003633 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00003633 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00003633 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00003633 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00003633 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00003633 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00003633 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00003633 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00003633 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00003633 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00003633 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00003633 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00003633 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00003633 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00003633 | 1 / 8 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00003633 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00003633 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00003633 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00003633 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00003633 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00003633 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00003633 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00003633 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00003633 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00003633 | 1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00003625 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00003633 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00003633 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00003633 | 2 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00003633 | 2 / 2 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00003633 | 2 / 0 |
O75496 | Geminin | Unclassified protein | C00003633 | 0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00003633 | 0 / 0 |
Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00003633 | 0 / 0 |
P46721 | Solute carrier organic anion transporter family member 1A2 | Unclassified protein | C00003633 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00003633 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00003633 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00003633 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00003633 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00003633 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00003633 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00003633 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00003633 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00003633 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00003633 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00003633 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00003633 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00003633 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00003633 | 1 / 0 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00003633 | 1 / 2 |
P03956 | Interstitial collagenase | M10A | C00003633 | 0 / 1 |
P54707 | Potassium-transporting ATPase alpha chain 2 | Potassium-transporting P-type ATPase alpha subunit | C00003633 | 0 / 0 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00003633 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00003633 | 7 / 3 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00003633 | 1 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00003633 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00003633 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00003633 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00003633 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00003633 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00003633 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00003633 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00003633 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00003633 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00003633 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00003633 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00003633 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00003633 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00003633 | 2 / 1 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00003633 | 0 / 3 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00003633 | 1 / 1 |
P29466 | Caspase-1 | C14 | C00003633 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00003633 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00003633 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00003633 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00003633 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00003633 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00003633 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00003633 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00003633 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00003633 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00003633 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00003633 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00003633 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00003633 | 0 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00003633 | 0 / 0 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00003633 | 1 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00003633 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00003633 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00003633 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00003633 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00003633 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00003633 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00003633 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00003633 | 0 / 1 |
P31939 | Bifunctional purine biosynthesis protein PURH | Enzyme | C00003633 | 1 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00003633 | 0 / 0 |
P42224 | Signal transducer and activator of transcription 1-alpha/beta | Unclassified protein | C00003633 | 3 / 3 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00003633 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00003633 | 1 / 0 |
Q6ZQN7 | Solute carrier organic anion transporter family member 4C1 | Unclassified protein | C00003633 | 0 / 0 |
Q9NYB5 | Solute carrier organic anion transporter family member 1C1 | Unclassified protein | C00003633 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00003613
C00003633
|
5111 | PCNA | proliferating cell nuclear antigen |
C00003633
|
10449 | ACAA2, DSAEC | acetyl-CoA acyltransferase 2 (EC:2.3.1.16) |
C00003633
|
59 | ACTA2, AAT6, ACTSA, MYMY5 | actin, alpha 2, smooth muscle, aorta |
C00003633
|
126 | ADH1C, ADH3 | alcohol dehydrogenase 1C (class I), gamma polypeptide (EC:1.1.1.1) |
C00003633
|
301 | ANXA1, ANX1, LPC1 | annexin A1 |
C00003633
|
302 | ANXA2, ANX2, ANX2L4, CAL1H, LIP2, LPC2, LPC2D, P36, PAP-IV | annexin A2 |
C00003633
|
369 | ARAF, A-RAF, ARAF1, PKS2, RAFA1 | v-raf murine sarcoma 3611 viral oncogene homolog (EC:2.7.11.1) |
C00003633
|
25820 | ARIH1, ARI, HARI, HHARI, UBCH7BP | ariadne RBR E3 ubiquitin protein ligase 1 |
C00003633
|
10092 | ARPC5, ARC16, dJ127C7.3, p16-Arc | actin related protein 2/3 complex, subunit 5, 16kDa |
C00003633
|
408 | ARRB1, ARB1, ARR1 | arrestin, beta 1 |
C00003633
|
427 | ASAH1, AC, ACDase, ASAH, PHP, PHP32, SMAPME | N-acylsphingosine amidohydrolase (acid ceramidase) 1 (EC:3.5.1.23) |
C00003633
|
479 | ATP12A, ATP1AL1 | ATPase, H+/K+ transporting, nongastric, alpha polypeptide (EC:3.6.3.10) |
C00003633
|
476 | ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9) |
C00003633
|
477 | ATP1A2, FHM2, MHP2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide (EC:3.6.3.9) |
C00003633
|
478 | ATP1A3, AHC2, DYT12, RDP | ATPase, Na+/K+ transporting, alpha 3 polypeptide (EC:3.6.3.9) |
C00003633
|
496 | ATP4B, ATP6B | ATPase, H+/K+ exchanging, beta polypeptide |
C00003633
|
498 | ATP5A1, ATP5A, ATP5AL2, ATPM, MC5DN4, MOM2, OMR, ORM, hATP1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
C00003633
|
22893 | BAHD1 | bromo adjacent homology domain containing 1 |
C00003633
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00003633
|
51806 | CALML5, CLSP | calmodulin-like 5 |
C00003633
|
821 | CANX, CNX, IP90, P90 | calnexin |
C00003633
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00003633
|
64770 | CCDC14 | coiled-coil domain containing 14 |
C00003633
|
8900 | CCNA1 | cyclin A1 |
C00003633
|
890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00003633
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00003633
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003633
|
9076 | CLDN1, CLD1, ILVASC, SEMP1 | claudin 1 |
C00003633
|
10330 | CNPY2, HP10390, MSAP, TMEM4, ZSIG9 | canopy FGF signaling regulator 2 |
C00003633
|
1537 | CYC1, MC3DN6, UQCR4 | cytochrome c-1 |
C00003633
|
1650 | DDOST, AGER1, CDG1R, OKSWcl45, OST, OST48, WBP1 | dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic) (EC:2.4.99.18) |
C00003633
|
1812 | DRD1, DADR, DRD1A | dopamine receptor D1 |
C00003633
|
1828 | DSG1, CDHF4, DG1, DSG, EPKHIA, PPKS1, SPPK1 | desmoglein 1 |
C00003633
|
1854 | DUT, dUTPase | deoxyuridine triphosphatase (EC:3.6.1.23) |
C00003633
|
1889 | ECE1, ECE | endothelin converting enzyme 1 (EC:3.4.24.71) |
C00003633
|
1892 | ECHS1, SCEH | enoyl CoA hydratase, short chain, 1, mitochondrial (EC:4.2.1.17) |
C00003633
|
27335 | EIF3K, EIF3-p28, EIF3S12, HSPC029, M9, MSTP001, PLAC-24, PLAC24, PRO1474, PTD001 | eukaryotic translation initiation factor 3, subunit K |
C00003633
|
10667 | FARS2, COXPD14, FARS1, HSPC320, PheRS, dJ520B18.2 | phenylalanyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.20) |
C00003633
|
2271 | FH, HLRCC, LRCC, MCL, MCUL1 | fumarate hydratase (EC:4.2.1.2) |
C00003633
|
51661 | FKBP7, FKBP23, PPIase | FK506 binding protein 7 (EC:5.2.1.8) |
C00003633
|
2638 | GC, DBP, DBP/GC, GRD3, VDBG, VDBP | group-specific component (vitamin D binding protein) (EC:6.4.-.-) |
C00003633
|
2743 | GLRB, HKPX2 | glycine receptor, beta |
C00003633
|
8225 | GTPBP6, PGPL | GTP binding protein 6 (putative) |
C00003633
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00003633
|
3181 | HNRNPA2B1, HNRNPA2, HNRNPB1, HNRPA2, HNRPA2B1, HNRPB1, IBMPFD2, RNPA2, SNRPB1 | heterogeneous nuclear ribonucleoprotein A2/B1 |
C00003633
|
9987 | HNRNPDL, HNRNP, HNRPDL, JKTBP, JKTBP2, laAUF1 | heterogeneous nuclear ribonucleoprotein D-like |
C00003633
|
3241 | HPCAL1, BDR1, HLP2, VILIP-3 | hippocalcin-like 1 |
C00003633
|
3273 | HRG, HPRG, HRGP, THPH11 | histidine-rich glycoprotein |
C00003633
|
3329 | HSPD1, CPN60, GROEL, HLD4, HSP-60, HSP60, HSP65, HuCHA60, SPG13 | heat shock 60kDa protein 1 (chaperonin) |
C00003633
|
3559 | IL2RA, CD25, IDDM10, IL2R, TCGFR | interleukin 2 receptor, alpha |
C00003633
|
3560 | IL2RB, CD122, IL15RB, P70-75 | interleukin 2 receptor, beta |
C00003633
|
3751 | KCND2, KV4.2, RK5 | potassium voltage-gated channel, Shal-related subfamily, member 2 |
C00003633
|
3757 | KCNH2, ERG1, HERG, HERG1, Kv11.1, LQT2, SQT1 | potassium voltage-gated channel, subfamily H (eag-related), member 2 |
C00003633
|
3956 | LGALS1, GAL1, GBP | lectin, galactoside-binding, soluble, 1 |
C00003633
|
4047 | LSS, OSC | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) (EC:5.4.99.7) |
C00003633
|
5598 | MAPK7, BMK1, ERK4, ERK5, PRKM7 | mitogen-activated protein kinase 7 (EC:2.7.11.24) |
C00003633
|
4191 | MDH2, M-MDH, MDH, MGC:3559, MOR1 | malate dehydrogenase 2, NAD (mitochondrial) (EC:1.1.1.37) |
C00003633
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00003633
|
10627 | MYL12A, MLCB, MRCL3, MRLC3, MYL2B | myosin, light chain 12A, regulatory, non-sarcomeric |
C00003633
|
10577 | NPC2, EDDM1, HE1 | Niemann-Pick disease, type C2 |
C00003633
|
2 | A2M, A2MD, CPAMD5, FWP007, S863-7 | alpha-2-macroglobulin |
C00003633
|
10016 | PDCD6, ALG-2, PEF1B | programmed cell death 6 |
C00003633
|
5204 | PFDN5, MM-1, MM1, PFD5 | prefoldin subunit 5 |
C00003633
|
5216 | PFN1, ALS18 | profilin 1 |
C00003633
|
9374 | PPT2, C6orf8, G14, PPT-2 | palmitoyl-protein thioesterase 2 (EC:3.1.2.22) |
C00003633
|
5694 | PSMB6, DELTA, LMPY, Y | proteasome (prosome, macropain) subunit, beta type, 6 (EC:3.4.25.1) |
C00003633
|
5771 | PTPN2, PTN2, PTPT, TC-PTP, TCELLPTP, TCPTP | protein tyrosine phosphatase, non-receptor type 2 (EC:3.1.3.48) |
C00003633
|
9230 | RAB11B, H-YPT3 | RAB11B, member RAS oncogene family |
C00003633
|
6093 | ROCK1, P160ROCK, ROCK-I | Rho-associated, coiled-coil containing protein kinase 1 (EC:2.7.11.1) |
C00003633
|
9475 | ROCK2, ROCK-II | Rho-associated, coiled-coil containing protein kinase 2 (EC:2.7.11.1) |
C00003633
|
6119 | RPA3, REPA3 | replication protein A3, 14kDa |
C00003633
|
23322 | RPGRIP1L, CORS3, FTM, JBTS7, MKS5, NPHP8 | RPGRIP1-like |
C00003633
|
6284 | S100A13 | S100 calcium binding protein A13 |
C00003633
|
6446 | SGK1, SGK | serum/glucocorticoid regulated kinase 1 (EC:2.7.11.1) |
C00003633
|
10110 | SGK2, H-SGK2, dJ138B7.2 | serum/glucocorticoid regulated kinase 2 (EC:2.7.11.1) |
C00003633
|
23678 | SGK3, CISK, SGK2, SGKL | serum/glucocorticoid regulated kinase family, member 3 (EC:2.7.11.1) |
C00003633
|
6528 | SLC5A5, NIS, TDH1 | solute carrier family 5 (sodium/iodide cotransporter), member 5 |
C00003633
|
8884 | SLC5A6, SMVT | solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 |
C00003633
|
7167 | TPI1, TIM, TPI, TPID | triosephosphate isomerase 1 (EC:5.3.1.1) |
C00003633
|
7178 | TPT1, HRF, TCTP, p02, p23 | tumor protein, translationally-controlled 1 |
C00003633
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00003633
|
463 | ZFHX3, ATBF1, ATBT, ZNF927 | zinc finger homeobox 3 |
C00003633
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#608688 | Aicar transformylase/imp cyclohydrolase deficiency |
P31939
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#209950 | Atypical mycobacteriosis, familial |
P42224
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#613985 | Beta-thalassemia |
P68871
|
#603902 | Beta-thalassemia, dominant inclusion body type |
P68871
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#614162 | Candidiasis, familial, 7; candf7 |
P42224
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#114500 | Colorectal cancer; crc |
P84022
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 |
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#140700 | Heinz body anemias |
P68871
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive |
P42224
|
#159900 | Myoclonic dystonia |
P14416
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#603903 | Sickle cell anemia |
P68871
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) P68871 (marker) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) P68871 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H00966 | AICA-ribosiduria |
P31939
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00089 | IFN-gamma/IL-12 axis |
P42224
(related)
|
H00363 | Candidiasis |
P42224
(related)
|
H01109 | Chronic mucocutaneous candidiasis (CMC) |
P42224
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00228 | Thalassemia |
P68871
(related)
|
H00229 | Sickle cell anemia (SCA) |
P68871
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D000014 | Abnormalities, Drug-Induced |
C00003633
|
D000647 | Amnesia |
C00003633
|
D001145 | Arrhythmias, Cardiac |
C00003633
|
D001281 | Atrial Fibrillation |
C00003633
|
D001714 | Bipolar Disorder |
C00003633
|
D001919 | Bradycardia |
C00003633
|
D001927 | Brain Diseases |
C00003633
|
D001929 | Brain Edema |
C00003633
|
D020520 | Brain Infarction |
C00003633
|
D001930 | Brain Injuries |
C00003633
|
D002303 | Cardiac Output, Low |
C00003633
|
D006332 | Cardiomegaly |
C00003633
|
D003251 | Constriction, Pathologic |
C00003633
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00003633
|
D006323 | Heart Arrest |
C00003633
|
D006327 | Heart Block |
C00003633
|
D006331 | Heart Diseases |
C00003633
|
D006948 | Hyperkinesis |
C00003633
|
D006973 | Hypertension |
C00003633
|
D020925 | Hypoxia-Ischemia, Brain |
C00003633
|
D009336 | Necrosis |
C00003633
|
D009410 | Nerve Degeneration |
C00003633
|
D010243 | Paralysis |
C00003633
|
D012164 | Retinal Diseases |
C00003633
|
D012640 | Seizures |
C00003633
|
D020182 | Sleep Apnea, Central |
C00003633
|
D013610 | Tachycardia |
C00003633
|
D013616 | Tachycardia, Sinus |
C00003633
|
D017180 | Tachycardia, Ventricular |
C00003633
|
D014570 | Urologic Diseases |
C00003633
|
D014693 | Ventricular Fibrillation |
C00003633
|
D018879 | Ventricular Premature Complexes |
C00003633
|
D015837 | Vestibular Diseases |
C00003633
|